-transparent.png){kind=logo}
We have used recombinant human (rh) GM-CSF in two 12-year-old Fanconi's aplastic anaemia patients. They had not received any previous therapy except blood transfusions. Each patient was given three 21 d courses of rh-GM-CSF, the first two at a dose of 3.5 micrograms/kg/d and the third at 7 micrograms/kg/d s.c. There were significant increases in WBC and absolute neutrophil counts after the first week of rh-GM-CSF which lasted as long as the treatment was continued. Following the cessation of treatment, WBC and ANC dropped rapidly. We conclude that rh-GM-CSF can be used in FAA, especially in severely neutropenic cases.
Related Publications
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
January 1961,
Lancet (London, England),
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
January 1995,
Pediatric nursing,
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
July 1974,
The Journal of the Association of Physicians of India,
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
August 2003,
British journal of haematology,
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
January 1971,
Indian pediatrics,
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
April 1973,
The Quarterly journal of medicine,
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
January 1995,
Lancet (London, England),
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
January 1991,
Bone marrow transplantation,
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
January 2003,
Anales del sistema sanitario de Navarra,
S Kemahli, and
D Canatan, and
Z Uysal, and
N Akar, and
S Cin, and
A Arcasoy
March 1964,
Irish journal of medical science,
